Related Experiment Video
Updated: Feb 7, 2026

In vivo Measurement of Knee Extensor Muscle Function in Mice
Published on: March 4, 2021
[Antagonistic function of the heart muscle : Part II: Clinical implications]
P P Lunkenheimer1, P Niederer2, J M Lunkenheimer3
1Experimentelle Thorax‑, Herz- und Gefäßchirurgie, Universitätskliniken Münster, Münster, Deutschland. P.P.Lunkenheimer@web.de.
Insights
Myocardial hypertrophy is worsened by myostructural afterload and connective tissue changes. Targeted negative inotropic medication and optimized mechanical support may offer new therapeutic avenues for heart disease.
Area of Science:
- Cardiovascular Physiology
- Cardiac Pathophysiology
Background:
- Hypertrophic heart disease is characterized by predominant myostructural afterload from endoepicardial networks, exacerbating myocardial hypertrophy.
- The intrinsic antagonism within the heart muscle is disrupted, leading to increased connective tissue (stromatogenic afterload) and regional cardiac dysfunction.
Purpose of the Study:
- To explore the mechanisms underlying myocardial hypertrophy and identify potential therapeutic targets.
- To evaluate the efficacy of negative inotropic medication and mechanical circulatory support in managing hypertrophic heart conditions.
- To propose novel diagnostic approaches for assessing myocardial stiffness and local motion patterns.
Main Methods:
- Analysis of myostructural and stromatogenic afterload in hypertrophic hearts.
- Assessment of the susceptibility of the myocardial network to negative inotropic agents.
- Evaluation of volume reduction surgery and external mechanical circulatory support parameters.
- Consideration of takotsubo cardiomyopathy as a model for intrinsic antagonism dysfunction.
Main Results:
- The oblique transmural myocardial network shows selective susceptibility to low-dose negative inotropic medication, suggesting a potential to attenuate hypertrophy.
- Volume reduction surgery is effective in reducing wall stress, provided the myocardium is not severely fibrotic.
- External mechanical circulatory support is most effective when maintaining the heart in a resting state with minimal motion.
Conclusions:
- Targeting the auxotonic, contracting myocardial network with negative inotropic medication may slow hypertrophic progression.
- Optimizing mechanical circulatory support for resting heart function is crucial for efficacy.
- Clinical diagnostics for heart disease require advancements focusing on local motion patterns and myocardial stiffness as markers of antagonistic intensity.
Abstract:
In the hypertrophic heart the myostructural afterload in the form of endoepicardial networks is predominant, which enhances myocardial hypertrophy. The intrinsic antagonism is derailed. Likewise, the connective tissue scaffold, i.e. the stromatogenic afterload, is enriched in the response to the derailment of antagonism in a hypertrophic heart up to regional captivation of the heart musculature. Due to the selective susceptibility of the auxotonic, contracting oblique transmural myocardial network for low dose negative inotropic medication, this promises to attenuate progress in myocardial hypertrophy. Volume reduction surgery is most effective in reducing wall stress as long as the myocardium is not critically fettered by fibrosis. The use of external mechanical circulatory support is then effective if the heart is supported in its resting mode, which means around a middle width and at minimal amplitude of motion. The takotsubo cardiomyopathy might possibly reflect an isolated, extreme stimulation of the intrinsic antagonism as a response to hormonally induced sensitization of the myocardium to catecholamine. A particular significant conclusion with respect to the diseased heart is that clinical diagnostics need new impulses with a focus on the analysis of local motion patterns and on myocardial stiffness reflecting disease-dependent antagonistic intensity. This would become a relevant diagnostic marker if corresponding (noninvasive) measurement techniques would become available.
Related Concept Videos
Heart Failure III: Clinical Manifestations
Functions of Smooth Muscles
Function of visceral smooth muscles
Visceral smooth muscle is found in the walls of all hollow organs, except the heart, and is a key player in the involuntary movements that drive the functioning of these internal organs. This tissue is arranged in...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Anatomy of the Heart
Cholinergic Antagonists: Pharmacokinetics
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...

